Vortrag am FONDS professionell KONGRESSFranklin Genomic Advancements Fund - N (acc) EUR
| MVD-Fonds Rating | EDA |
|---|---|
  | - |
ISIN: LU2387457729 | WKN: A3C4V6
KAG: Franklin Templeton
NAV: 6,71 EUR am 09.12.2025
Portfolio
Watchlist
KursalarmChart
Kennzahlen Franklin Genomic Advancements Fund - N (acc) EUR
| 1M | 6M | 1J | 3J | 5J | 10J | Beginn | |
| Performance | +4,35% | +31,31% | +5,34% | +2,44% | - | - | -32,90% |
| Volatilität | +21,17% | +17,95% | +24,23% | +19,84% | - | - | +22,27% |
| Sharpe Ratio | +3,26 | +3,91 | +0,13 | -0,06 | - | - | -0,50 |
| Bester Monat | - | +15,60% | +15,60% | +15,60% | +15,60% | - | +15,60% |
| Schl. Monat | - | -3,87% | -11,80% | -11,80% | -18,20% | - | -18,20% |
| Max. Verlust | -4,01% | -5,16% | -26,89% | -30,65% | - | - | -55,71% |
Monatsperformance Franklin Genomic Advancements Fund - N (acc) EUR
| 2025 | 2024 | 2023 | 2022 | 2021 | |
| Januar | +5,79% | -0,33% | +3,62% | -18,20% | - |
| Februar | -4,69% | +7,72% | -3,95% | -3,75% | - |
| März | -11,80% | +1,83% | -0,47% | -0,78% | - |
| April | -3,90% | -7,34% | -3,50% | -7,59% | - |
| Mai | -5,42% | +1,45% | +1,81% | +0,42% | - |
| Juni | +3,27% | +3,18% | 0,00% | -1,55% | - |
| Juli | +3,17% | +4,78% | +2,59% | +12,75% | - |
| August | +4,80% | -3,24% | -0,32% | -8,01% | - |
| September | +3,30% | -3,65% | -5,70% | -5,39% | - |
| Oktober | +15,60% | -4,90% | -10,23% | +3,36% | - |
| November | +7,06% | +5,32% | +5,98% | -1,84% | -4,72% |
| Dezember | -3,87% | -4,57% | +7,76% | -8,63% | -3,07% |
| Gesamt | +10,92% | -0,99% | -3,78% | -35,08% | -7,65% |
Diese Fonds könnten Sie auch interessieren
Vergleichen Sie diese Fonds mit Ihrem ausgewähltem Fonds (Franklin Genomic Advancements Fund) oder suchen Sie weitere Top-Fonds zum Thema Aktien (Branche Gesundheit/Pharma) weltweit in EUR:
Fonds vergleichenWeitere ähnliche Fonds